NITROFURANTOIN (nitrofurantoin) by Aurobindo Pharma is 12. Approved for pyelonephritis, perinephric abscesses [see ], perinephric abscesses and 1 more indications. First approved in 2025.
Drug data last refreshed 18h ago
12.1 Mechanism of Action Nitrofurantoin is an antibacterial drug [ see ] . 12.2 Pharmacodynamics Pharmacodynamic effects of nitrofurantoin oral suspension are unknown. 12.3 Pharmacokinetics Absorption Orally administered nitrofurantoin oral suspension is readily absorbed. Blood concentrations at…
Worked on NITROFURANTOIN at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Nitrofuran Antibacterial
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis